Copper (II) complexes supported by phenyl selanyl ligands: DNA binding and molecular docking studies
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Copper II complexes (3a-d) with (16E) -2,6-dimethyl-N-(2-phenylquinoline-4(1H)-ylidene)-5-(phenylselanyl) pyrimidine-4-amine ligands have been developed. They have been characterised by elemental analysis and several spectroscopic studies. Absorption spectra, fluroscence investigations, and viscosity tests reveal how the copper complexes interact with the calf thymus (CT-DNA). Furthermore, the ligand's ability to inhibit acetylcholinesterase (AChE) has been studied in order to establish its efficacy in the treatment of neurodegenerative diseases. Compared to normal Rivastigmine and Galantamine, the synthesised ligand 2c shows selective inhibition (AChE and BuChE) with IC50 values of 0.18 and 3.03 μM. A molecular docking study was carried out.
Fields of Study & Subjects
Metal complexes synthesis and properties
Inorganic and Organometallic Chemistry
Heterocyclic Compound Synthesis and Bioactivity
Publication details
- Journal / source
- Indian Journal of Chemistry
- Volume
- 65
- Issue
- 3
- Publication date
- 27 March 2026
- Language
- EN